|Trial status||Trial open for recruitment|
Interventional with experimental drug
|Phase||Trial phase 3|
|Sponsor||Innovent Biologics (Suzhou) Co., Ltd.|
The new Institut Jules Bordet, a building for the practice of medical excellence now and in the future. Meeting at the end of November 2021 on the ULB campus in Anderlecht.